18 results
10-K
2023 FY
MIRA
Mira Pharmaceuticals Inc
1 Apr 24
Annual report
7:00am
annually. MDD is also a major risk factor for suicide, a leading cause of death globally, highlighting its profound impact on public health … believe that its use, or a person’s exposure to it, may cause adverse health consequences or death. To date we have not withdrawn, recalled, or taken any
424B4
MIRA
Mira Pharmaceuticals Inc
4 Aug 23
Prospectus supplement with pricing info
1:01pm
to it, may cause adverse health consequences or death. To date we have not withdrawn, recalled, or taken any other action, voluntary or mandatory, to remove … in writing a beneficiary to exercise the award or receive payment under the award after the participant’s death, (b) transfer an award to a former
424B1
MIRA
Mira Pharmaceuticals Inc
4 Aug 23
Prospectus with pricing info
12:59pm
consequences or death. To date we have not withdrawn, recalled, or taken any other action, voluntary or mandatory, to remove an approved product from … in writing a beneficiary to exercise the award or receive payment under the award after the participant’s death, (b) transfer an award to a former
S-1
EX-3.1
5hq3aive
29 Jun 23
IPO registration
4:39pm
S-1
gnic7z0k sv9cyefb24j
29 Jun 23
IPO registration
4:39pm
S-1
EX-10.5
71twd9oigt 620
29 Jun 23
IPO registration
4:39pm
S-1
EX-3.2
q2y19stpmi
29 Jun 23
IPO registration
4:39pm
S-1
EX-10.2
zkxgtv35biz3
29 Jun 23
IPO registration
4:39pm
S-1
EX-10.1
73dsuchnxi6yxn2oomc4
29 Jun 23
IPO registration
4:39pm
DRS/A
EX-10.5
ocaxv9g2l
8 Jun 23
Draft registration statement (amended)
12:00am
DRS/A
rscf59zpp
8 Jun 23
Draft registration statement (amended)
12:00am
DRS/A
10ws0a8jwq9ig0zpy
2 May 23
Draft registration statement (amended)
12:00am
DRS
a7pa6 19oqflhlgl
29 Jun 22
Draft registration statement
12:00am
- Prev
- 1
- Next